Kaixiong Liu

841 citations
25 papers · 574 indexed · h-index 13
Topics
Gut microbiota and health (5 papers)Pulmonary Hypertension Research and Treatments (4 papers)Pneumonia and Respiratory Infections (3 papers)
Partner nations
ChinaUnited States

In The Last Decade

Kaixiong Liu

25 papers receiving 567 citations

Peers

Kaixiong Liu
Comparison fields: 5 of 91
  • Molecular Biology 199
  • Pulmonary and Respiratory Medicine 185
  • Epidemiology 137
  • Infectious Diseases 101
  • Physiology 97
Replace Abdul Rehman with:
Abdul Rehman Pakistan
Mei‐Yung Chung Taiwan
Ileana Herzum Germany
Gidon Berger Israel
Josef Yayan Germany
Albert Castellheim Norway
Guglielmo Tellan Italy
Qiuping Li China
Huang-Pin Wu Taiwan
Fang Huang China
Kaixiong Liu relative to Abdul Rehman Pakistan Abdul Rehman's profile →
Citations per field
00.5×1.5×1.9×
Abdul Rehman · 1×
Citations per year

Countries citing papers authored by Kaixiong Liu

Since Specialization
Citations

This map shows the geographic impact of Kaixiong Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kaixiong Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kaixiong Liu more than expected).

Fields of papers citing papers by Kaixiong Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kaixiong Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kaixiong Liu. The network helps show where Kaixiong Liu may publish in the future.

Co-authorship network of co-authors of Kaixiong Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Kaixiong Liu. A scholar is included among the top collaborators of Kaixiong Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kaixiong Liu. Kaixiong Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 10
3 1
4 3
5 4
6 6
7 8
8 21
9 46
10 21
11 41
12 22
13 48
14 4
15 33
16 11
17 41
18 127
19 32
20 44

About Kaixiong Liu

Kaixiong Liu is a scholar working on Microbiology, Internal Medicine and Pulmonary and Respiratory Medicine, having authored 25 papers that have together received 574 indexed citations. Recurring topics across this work include Gut microbiota and health (5 papers), Pulmonary Hypertension Research and Treatments (4 papers) and Pneumonia and Respiratory Infections (3 papers). The work is most often cited by research in Critical Care and Intensive Care Medicine (59 citations), Pulmonary and Respiratory Medicine (185 citations) and Infectious Diseases (101 citations). Kaixiong Liu has collaborated with scholars based in China and United States. Frequent co-authors include Jieming Qu, Xiaodan Wang, Jin Yang, Jieming Qu, Guofu Lin, Lili Tao, Jing Zhang, Haibo Ding, Huidan Weng and Jun Lü. Their work appears in journals such as PLoS ONE, Life Sciences and European Journal of Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026